Pricing Log in Create free account

Atrinsic Inc. (PTIX) vs SciSparc Ltd. (SPRC)

Atrinsic Inc. and SciSparc Ltd. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $1.2M — 1.1× the size. SciSparc Ltd. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 10 metrics below, SciSparc Ltd. leads on 6 and Atrinsic Inc. on 4.

Valuation

Metric PTIX SPRC Biotechnology median
P/E 0.34 n/m 8.50
P/S n/m n/m 9.71
P/B 0.79 0.53 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 297.33% (4,191.76%) (33.15%)
Free cash flow yield (158.74%) (129.31%) (25.50%)

Profitability

Metric PTIX SPRC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (338.24%) 0.00% (56.36%)
Return on assets 378.63% 0.00% (48.04%)
Return on invested capital (229.86%) 0.00% 0.00%

Growth

Metric PTIX SPRC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 188.24% 59.48% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTIX SPRC Biotechnology median
Debt to equity 0.00 0.24 0.00
Current ratio 0.66 0.87 4.72
Net debt to EBITDA 0.52 0.52 0.96

Dividend

Metric PTIX SPRC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PTIX SPRC Biotechnology median
Market cap 1.27m 1.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack